Advanced search
Publication Cover
Cancer Biology & Therapy Volume 14, 2013 - Issue 6
Submit an article Journal homepage
1,074
Views
67
CrossRef citations to date
0
Altmetric
Bedside to Bench Report

Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients

Cirino Botta Medical Oncology Unit; Campus Salvatore Venuta; Department of Experimental and Clinical Medicine; “Magna Graecia” University and “Tommaso Campanella” Cancer Center; Catanzaro, Italy
,
Vito Barbieri Medical Oncology Unit; Campus Salvatore Venuta; Department of Experimental and Clinical Medicine; “Magna Graecia” University and “Tommaso Campanella” Cancer Center; Catanzaro, Italy
,
Domenico Ciliberto Medical Oncology Unit; Campus Salvatore Venuta; Department of Experimental and Clinical Medicine; “Magna Graecia” University and “Tommaso Campanella” Cancer Center; Catanzaro, Italy
,
Antonio Rossi Division of Medical Oncology; “S.G. Moscati” Hospital; Avellino, Italy
,
Danilo Rocco AORN Vincenzo Monaldi; Naples, Italy
,
Raffaele Addeo Oncology Unit; “S. Giovanni di Dio” Hospital, Frattamaggiore; Naples, Italy
,
Nicoletta Staropoli Medical Oncology Unit; Campus Salvatore Venuta; Department of Experimental and Clinical Medicine; “Magna Graecia” University and “Tommaso Campanella” Cancer Center; Catanzaro, Italy
,
Pierpaolo Pastina Unit of Radiotherapy; Siena University School of Medicine; Siena, Italy
,
Giulia Marvaso Medical Oncology Unit; Campus Salvatore Venuta; Department of Experimental and Clinical Medicine; “Magna Graecia” University and “Tommaso Campanella” Cancer Center; Catanzaro, Italy
,
Ignazio Martellucci Medical Oncology Unit Department of Oncology; Siena University School of Medicine; Siena, Italy
,
Annamaria Guglielmo Unit of Radiotherapy; Siena University School of Medicine; Siena, Italy
,
Luigi Pirtoli Unit of Radiotherapy; Siena University School of Medicine; Siena, Italy
,
Pasquale Sperlongano Surgery Department; Biophysics and General Pathology; Second University of Naples; Naples, Italy
,
Cesare Gridelli Division of Medical Oncology; “S.G. Moscati” Hospital; Avellino, Italy
,
Michele Caraglia Department of Biochemistry, Biophysics and General Pathology; Second University of Naples; Naples, Italy; Temple University College of Science & Technology; Philadelphia, PA USACorrespondence[email protected]
,
Pierfrancesco Tassone Medical Oncology Unit; Campus Salvatore Venuta; Department of Experimental and Clinical Medicine; “Magna Graecia” University and “Tommaso Campanella” Cancer Center; Catanzaro, Italy; Temple University College of Science & Technology; Philadelphia, PA USA
,
Pierosandro Tagliaferri Medical Oncology Unit; Campus Salvatore Venuta; Department of Experimental and Clinical Medicine; “Magna Graecia” University and “Tommaso Campanella” Cancer Center; Catanzaro, Italy
&
Pierpaolo Correale Unit of Radiotherapy; Siena University School of Medicine; Siena, Italy
 show all
Pages 469-475 | Received 10 Feb 2013, Accepted 23 Mar 2013, Published online: 10 Apr 2013

Citations (67)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Xinran Li, Jiamin Zheng, Min Yan, Ye Lu & Xiangtao Pan. (2022) The Significance of Fibrinogen in Combination with the Neutrophil to Lymphocyte Ratio in Predicting the Prognosis of Patients with Gastric Cancer. Cancer Management and Research 14, pages 2313-2321.
Read now
Rong Chen, Fang-Ying Lu, Bing Liu, Jingwen Huang, Min Zhou, Ranran Dai & Yi Guo. (2021) Absolute Neutrophil Count in the Peripheral Blood Predicts Prognosis in Lung Cancer Patients Treated with Anlotinib. Cancer Management and Research 13, pages 3619-3627.
Read now
Xianhe Xie, Junjin Liu, Haitao Yang, Huijuan Chen, Sijing Zhou, Heng Lin, Ziyuan Liao, Yin Ding, Liting Ling & Xuewen Wang. (2019) Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Outcome of Immune Checkpoint Inhibitors. Cancer Investigation 37:6, pages 265-274.
Read now
Thang Thanh Phan, Toan Trong Ho, Hue Thi Nguyen, Hang Thuy Nguyen, Thu Bich Tran & Son Truong Nguyen. (2018) The prognostic impact of neutrophil to lymphocyte ratio in advanced non-small cell lung cancer patients treated with EGFR TKI. International Journal of General Medicine 11, pages 423-430.
Read now
C Hardin, E Shum, AP Singh, R Perez-Soler & H Cheng. (2017) Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer. Expert Opinion on Pharmacotherapy 18:7, pages 701-716.
Read now
Yanyang Liu, Li Tu, Li Wang, Jianlin Long, Jiantao Wang, Yuyi Wang, Feng Luo & Dan Cao. (2016) The accumulation of macrophages attenuates the effect of recombinant human endostatin on lung cancer. OncoTargets and Therapy 9, pages 6581-6595.
Read now
Valerio Nardone, Cirino Botta, Michele Caraglia, Elodia Claudia Martino, Maria Raffaella Ambrosio, Tommaso Carfagno, Paolo Tini, Leonardo Semeraro, Gabriella Misso, Anna Grimaldi, Mariarosaria Boccellino, Gaetano Facchini, Massimiliano Berretta, Gianluca Vischi, Bruno Jim Rocca, Aurora Barone, Pierfrancesco Tassone, Pierosandro Tagliaferri, Maria Teresa del Vecchio, Luigi Pirtoli & Pierpaolo Correale. (2016) Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse. Cancer Biology & Therapy 17:11, pages 1213-1220.
Read now
Pierpaolo Correale, Cirino Botta, Elodia Claudio Martino, Cristina Ulivieri, Giuseppe Battaglia, Tommaso Carfagno, Maria Grazia Rossetti, Antonella Fioravanti, Giacomo Maria Guidelli, Sara Cheleschi, Claudia Gandolfo, Francesco Carbone, Tatiana Cosima Baldari, Pierfrancesco Tassone, Pierosandro Tagliaferri, Luigi Pirtoli & Maria Grazia Cusi. (2016) Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients. OncoImmunology 5:4.
Read now
Qing-Tao Zhao, Yong Yang, Shun Xu, Xiao-Peng Zhang, Hui-En Wang, Hua Zhang, Zhi-Kang Wang, Zheng Yuan & Guo-Chen Duan. (2015) Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients. OncoTargets and Therapy 8, pages 2731-2738.
Read now
Domenico Ciliberto, Nicoletta Staropoli, Francesca Caglioti, Simona Gualtieri, Lucia Fiorillo, Silvia Chiellino, Antonina Maria De Angelis, Francesco Mendicino, Cirino Botta, Michele Caraglia, Pierfrancesco Tassone & Pierosandro Tagliaferri. (2015) A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?. Cancer Biology & Therapy 16:8, pages 1148-1159.
Read now

Articles from other publishers (57)

Antonella Fameli, Valerio Nardone, Mojtaba Shekarkar Azgomi, Giovanna Bianco, Claudia Gandolfo, Bianca Maria Oliva, Marika Monoriti, Rita Emilena Saladino, Antonella Falzea, Caterina Romeo, Natale Daniele Calandruccio, Domenico Azzarello, Rocco Giannicola, Luigi Pirtoli, Antonio Giordano, Pierfrancesco Tassone, Pierosandro Tagliaferri, Maria Grazia Cusi, Luciano Mutti, Cirino Botta & Pierpaolo Correale. (2022) PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach. Frontiers in Oncology 12.
Crossref
Yongchao Zhang, Bozhi Liu, Sergei Kotenko & Wei Li. (2022) Prognostic value of neutrophil-lymphocyte ratio and lactate dehydrogenase in melanoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Medicine 101:32, pages e29536.
Crossref
Saeed Karimi, Amir Arabi, Toktam Shahraki & Sare Safi. (2022) Association of White Blood Cell Counts, Leukocyte Ratios, and Serum Uric Acid with Clinical Outcome of Intravitreal Bevacizumab in Diabetic Macular Edema. Korean Journal of Ophthalmology 36:3, pages 244-252.
Crossref
Jingru Yang, Mingliang Deng, Minghong Bi, Yaping Wang, Xuxu Qiao & Shanshan Zhang. (2022) Prognostic values of inflammatory indexes in bevacizumab-treated patients with advanced non-small-cell lung cancer. Future Science OA 8:5.
Crossref
Xueping Wang, Zhonglian He, Wen Liu, Runkun Han, Huilan Li, Shuqin Dai, Lin Zhang & Minjie Mao. (2022) Development of a Clinically Oriented Model to Predict Antitumor Effects after PD-1/PD-L1 Inhibitor Therapy. Journal of Oncology 2022, pages 1-11.
Crossref
Zeynep Keskin & Mihrican Yesildag. (2022) The evaluation of the association between the prevalence and patterns of computed tomography findings of cryptogenic organizing pneumonia, and neutrophil/lymphocyte and platelet/lymphocyte ratios. Chinese Journal of Academic Radiology 5:1, pages 61-68.
Crossref
Xue Cao, Xiaolin Wang, Heng Wang, Gaopo Xu & Huichuan Yu. (2022) Systemic Inflammation Status Relates to Anti–inflammatory Drug Benefit and Survival in Rectal Cancer. Journal of Surgical Research 269, pages 249-259.
Crossref
Liang Guo, Qi Wang, Kang Chen, Hai-Peng Liu & Xiao Chen. (2021) Prognostic Value of Combination of Inflammatory and Tumor Markers in Resectable Gastric Cancer. Journal of Gastrointestinal Surgery 25:10, pages 2470-2483.
Crossref
Jiatao Liao, Chang Liu, Qianqian Long, Xianghua Wu, Huijie Wang, Hui Yu, Si Sun, Yao Zhang, Ying Lin, Xinmin Zhao & Jialei Wang. (2021) Direct Comparison Between the Addition of Pembrolizumab or Bevacizumab for Chemotherapy-Based First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer Lacking Driver Mutations. Frontiers in Oncology 11.
Crossref
Cirino Botta, Rita Maria Agostino, Vincenzo Dattola, Vittoria Cianci, Natale Daniele Calandruccio, Giovanna Bianco, Antonino Mafodda, Roberto Maisano, Eleonora Iuliano, Giovanna Orizzonte, Domenico Mazzacuva, Antonia Consuelo Falzea, Rita Emilena Saladino, Rocco Giannicola, Giorgio Restifo, Umberto Aguglia, Michele Caraglia & Pierpaolo Correale. (2021) Myositis/Myasthenia after Pembrolizumab in a Bladder Cancer Patient with an Autoimmunity-Associated HLA: Immune–Biological Evaluation and Case Report. International Journal of Molecular Sciences 22:12, pages 6246.
Crossref
Adam Lauko, Bicky Thapa, Mayur Sharma, Baha’eddin Muhsen, Addison Barnett, Yasmeen Rauf, Hamid Borghei-Razavi, Vineeth Tatineni, Pradnya Patil, Alireza Mohammadi, Samuel Chao, Erin S. Murphy, Lilyana Angelov, John Suh, Gene H. Barnett, Amy S. Nowacki, Nathan Pennell & Manmeet S. Ahluwalia. (2021) Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases. Scientific Reports 11:1.
Crossref
Shogo Nakamoto, Masahiko Ikeda, Shinichiro Kubo, Mari Yamamoto, Tetsumasa Yamashita & Akifumi Notsu. (2021) Systemic immunity markers associated with lymphocytes predict the survival benefit from paclitaxel plus bevacizumab in HER2 negative advanced breast cancer. Scientific Reports 11:1.
Crossref
Shu Wen, Nan Chen, Ying Hu, Litao Huang, Jin Peng, Meina Yang, Xiaoyang Shen, Yang Song & Liangzhi Xu. (2021) Elevated peripheral absolute monocyte count related to clinicopathological features and poor prognosis in solid tumors: Systematic review, meta‐analysis, and meta‐regression. Cancer Medicine 10:5, pages 1690-1714.
Crossref
杰 张. (2021) Relationship between NLR and Efficacy of First-Line Chemotherapy for Chronic Obstructive Pulmonary Disease with Lung Cancer. Advances in Clinical Medicine 11:01, pages 403-409.
Crossref
Giuseppe Fanetti, Daniela Alterio, Giulia Marvaso, Sara Gandini, Damaris Patricia Rojas, Carlo Gobitti, Emilio Minatel, Alberto Revelant, Angela Caroli, Claudia Maria Francia, Ombretta Alessandro, Matteo Pepa, Simone Giovanni Gugliandolo, Anna Starzyńska, Jerry Polesel, Emanuela Vaccher, Maria Cossu Rocca, Marta Tagliabue, Mohssen Ansarin, Valentina Lupato, Vittorio Giacomarra, Antonino De Paoli, Roberto Orecchia, Giovanni Franchin & Barbara Alicja Jereczek‐Fossa. (2020) Prognostic significance of neutrophil‐to‐lymphocyte ratio in HPV status era for oropharyngeal cancer. Oral Diseases 26:7, pages 1384-1392.
Crossref
Yolla Haibe, Malek Kreidieh, Hiba El Hajj, Ibrahim Khalifeh, Deborah Mukherji, Sally Temraz & Ali Shamseddine. (2020) Resistance Mechanisms to Anti-angiogenic Therapies in Cancer. Frontiers in Oncology 10.
Crossref
Theodore S. Kapellos, Lorenzo Bonaguro, Ioanna Gemünd, Nico Reusch, Adem Saglam, Emily R. Hinkley & Joachim L. Schultze. (2019) Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases. Frontiers in Immunology 10.
Crossref
Nikhil Sebastian, Trudy Wu, Jose Bazan, Erin Driscoll, Henning Willers, Nikhil Yegya-Raman, Laura Bond, Abhishek Dwivedi, Xiaokui Mo, Yubo Tan, Meng Xu-Welliver, Karl Haglund, Salma K. Jabbour, Florence K. Keane & Terence M. Williams. (2019) Pre-treatment neutrophil-lymphocyte ratio is associated with overall mortality in localized non-small cell lung cancer treated with stereotactic body radiotherapy. Radiotherapy and Oncology 134, pages 151-157.
Crossref
Emma Guilbaud, Emmanuel L. Gautier & Laurent Yvan-Charvet. (2019) Macrophage Origin, Metabolic Reprogramming and IL-1 Signaling: Promises and Pitfalls in Lung Cancer. Cancers 11:3, pages 298.
Crossref
Sherif Raouf, Gianfilippo Bertelli, Agnes Ograbek, Polly Field & Irwin Tran. (2019) Real-world use of bevacizumab in metastatic colorectal, metastatic breast, advanced ovarian and cervical cancer: a systematic literature review. Future Oncology 15:5, pages 543-561.
Crossref
Weibin Hou & Stefan Duensing. 2019. Tumor Angiogenesis. Tumor Angiogenesis 293 310 .
Tao Jiang, Meng Qiao, Chao Zhao, Xuefei Li, Guanghui Gao, Chunxia Su, Shengxiang Ren & Caicun Zhou. (2018) Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysis. Cancer Immunology, Immunotherapy 67:5, pages 713-727.
Crossref
Yoshiro Itatani, Kenji Kawada, Takamasa Yamamoto & Yoshiharu Sakai. (2018) Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway. International Journal of Molecular Sciences 19:4, pages 1232.
Crossref
Pierpaolo Correale, Cirino Botta, Nicoletta Staropoli, Valerio Nardone, Pierpaolo Pastina, Cristina Ulivieri, Claudia Gandolfo, Tatiana Cosima Baldari, Stefano Lazzi, Domenico Ciliberto, Rocco Giannicola, Antonella Fioravanti, Antonio Giordano, Silvia Zappavigna, Michele Caraglia, Pierfrancesco Tassone, Luigi Pirtoli, Maria Grazia Cusi & Pierosandro Tagliaferri. (2018) Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine. Oncotarget 9:29, pages 20539-20554.
Crossref
Marco Rossi, Cirino Botta, Mariamena Arbitrio, Rosa Daniela Grembiale, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2018) Mouse models of multiple myeloma: technologic platforms and perspectives. Oncotarget 9:28, pages 20119-20133.
Crossref
C Botta, M Cucè, M R Pitari, D Caracciolo, A Gullà, E Morelli, C Riillo, L Biamonte, M E Gallo Cantafio, R Prabhala, C Mignogna, A Di Vito, E Altomare, N Amodio, M T Di Martino, P Correale, M Rossi, A Giordano, N C Munshi, P Tagliaferri & P Tassone. (2017) MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells. Leukemia 32:4, pages 1003-1015.
Crossref
Tatsunori Kiriu, Masatsugu Yamamoto, Tatsuya Nagano, Daisuke Hazama, Reina Sekiya, Masahiro Katsurada, Daisuke Tamura, Motoko Tachihara, Kazuyuki Kobayashi & Yoshihiro Nishimura. (2018) The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer. PLOS ONE 13:2, pages e0193018.
Crossref
Roberto Ronca, Mohammed Benkheil, Stefania Mitola, Sofie Struyf & Sandra Liekens. (2017) Tumor angiogenesis revisited: Regulators and clinical implications. Medicinal Research Reviews 37:6, pages 1231-1274.
Crossref
Wei Liu, Minwen Ha & Nanchang Yin. (2017) Combination of platelet count and lymphocyte to monocyte ratio is a prognostic factor in patients undergoing surgery for non-small cell lung cancer. Oncotarget 8:42, pages 73198-73207.
Crossref
Yu Yu, Lei Qian & Jiuwei Cui. (2017) Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients. Molecular and Clinical Oncology 7:3, pages 498-506.
Crossref
Zubing Mei, Lu Shi, Bo Wang, Jizhen Yang, Zhihong Xiao, Peixin Du, Qingming Wang & Wei Yang. (2017) Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies. Cancer Treatment Reviews 58, pages 1-13.
Crossref
Weibin Hou & Stefan Duensing. 2017. Tumor Angiogenesis. Tumor Angiogenesis 1 18 .
C Botta, M T Di Martino, D Ciliberto, M Cucè, P Correale, M Rossi, P Tagliaferri & P Tassone. (2016) A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival. Blood Cancer Journal 6:12, pages e511-e511.
Crossref
Yu-Mu Chen, Chien-Hao Lai, Kun-Ming Rau, Cheng-Hua Huang, Huang-Chih Chang, Tung-Ying Chao, Chia-Cheng Tseng, Wen-Feng Fang, Yu-Hsiu Chung, Yi-Hsi Wang, Mao-Chang Su, Kuo-Tung Huang, Shih-Feng Liu, Hung-Chen Chen, Ya-Chun Chang, Yu-Ping Chang, Chin-Chou Wang & Meng-Chih Lin. (2016) Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors. BMC Cancer 16:1.
Crossref
Hikaru Nakashima, Yuichiro Matsuoka, Ryoji Yoshida, Masashi Nagata, Akiyuki Hirosue, Kenta Kawahara, Junki Sakata, Hidetaka Arita, Akimitsu Hiraki & Hideki Nakayama. (2016) Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective study. BMC Cancer 16:1.
Crossref
Hong-Bo Yang, Meng Xing, Lei-Na Ma, Ling-Xin Feng & Zhuang Yu. (2016) Prognostic significance of neutrophil-lymphocyteratio/platelet-lymphocyteratioin lung cancers: a meta-analysis. Oncotarget 7:47, pages 76769-76778.
Crossref
Jun Wang, Neda Kalhor, Jianhua Hu, Baocheng Wang, Huili Chu, Bicheng Zhang, Yaping Guan & Yun Wu. (2016) Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer. PLOS ONE 11:10, pages e0163397.
Crossref
EC Martino, G Misso, P Pastina, S Costantini, F Vanni, C Gandolfo, C Botta, F Capone, A Lombardi, L Pirtoli, P Tassone, C Ulivieri, P Tagliaferri, MG Cusi, M Caraglia & P Correale. (2016) Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients. Cell Death Discovery 2:1.
Crossref
C Botta, G Misso, E C Martino, L Pirtoli, M G Cusi, P Tassone, P Tagliaferri, M Caraglia & P Correale. (2016) The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response. Cell Death & Disease 7:7, pages e2299-e2299.
Crossref
HUARONG TANG, HONGLIAN MA, FANG PENG, YONG BAO, XIAO HU, JIN WANG, YUJIN XU & MING CHEN. (2016) Prognostic performance of inflammation-based prognostic indices in locally advanced non-small-lung cancer treated with endostar and concurrent chemoradiotherapy. Molecular and Clinical Oncology 4:5, pages 801-806.
Crossref
Ying-Jian Song, Li-Xin Wang, Yong-Qing Hong, Zheng-Hong Lu, Qiang Tong, Xiao-Zheng Fang & Juan Tan. (2015) Lymphocyte to monocyte ratio is associated with response to first-line platinum-based chemotherapy and prognosis of early-stage non-small cell lung cancer patients. Tumor Biology 37:4, pages 5285-5293.
Crossref
Sarah Cattin, Benoît Fellay, Sylvain Pradervand, Andreas Trojan, Thomas Ruhstaller, Curzio Rüegg & Gregor Fürstenberger. (2016) Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients. Oncotarget 7:10, pages 11137-11150.
Crossref
Yu-Mu Chen, Chien-Hao Lai, Huang-Chih Chang, Tung-Ying Chao, Chia-Cheng Tseng, Wen-Feng Fang, Chin-Chou Wang, Yu-Hsiu Chung, Yi-Hsi Wang, Mao-Chang Su, Kuo-Tung Huang, Hung-cheng Chen & Meng-Chih Lin. (2016) The impact of clinical parameters on progression-free survival of non-small cell lung cancer patients harboring EGFR-mutations receiving first-line EGFR-tyrosine kinase inhibitors. Lung Cancer 93, pages 47-54.
Crossref
Wei Liang & Napoleone Ferrara. (2016) The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis. Cancer Immunology Research 4:2, pages 83-91.
Crossref
Jiahuai Wen, Feng Ye, Xiaojia Huang, Shuaijie Li, Lu Yang, Xiangsheng Xiao & Xiaoming Xie. (2015) Prognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer. Medicine 94:49, pages e2266.
Crossref
A. Romano, N. L. Parrinello, M. L. Consoli, L. Marchionni, S. Forte, C. Conticello, A. Pompa, A. Corso, G. Milone, F. Di Raimondo & I. Borrello. (2015) Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents. Annals of Hematology 94:11, pages 1875-1883.
Crossref
Maria Grazia Cusi, Cirino Botta, Pierpaolo Pastina, Maria Grazia Rossetti, Elena Dreassi, Giacomo Maria Guidelli, Antonella Fioravanti, Elodia Claudia Martino, Claudia Gandolfo, Marco Pagliuchi, Assunta Basile, Salvatore Francesco Carbone, Veronica Ricci, Lucia Micheli, Pierfrancesco Tassone, Pierosandro Tagliaferri, Luigi Pirtoli & Pierpaolo Correale. (2015) Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients. Cancer Immunology, Immunotherapy 64:9, pages 1159-1173.
Crossref
Xiao-Bin Gu, Tian Tian, Xiao-Jing Tian & Xiao-Jun Zhang. (2015) Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis. Scientific Reports 5:1.
Crossref
David G. Watt, John C. Martin, James H. Park, Paul G. Horgan & Donald C. McMillan. (2015) Neutrophil count is the most important prognostic component of the differential white cell count in patients undergoing elective surgery for colorectal cancer. The American Journal of Surgery 210:1, pages 24-30.
Crossref
Han Luo, Ding Yuan, Hongliu Yang, Ma Yukui, Bin Huang, Yi Yang, Fei Xiong, Guojun Zeng, Zhoupeng Wu, Xiyang Chen, Tiehao Wang, Hailong Luo & Jichun Zhao. (2015) Post-treatment neutrophil-lymphocyte ratio independently predicts amputation in critical limb ischemia without operation. Clinics 70:4, pages 273-277.
Crossref
Nathan A. Cannon, Jeffrey Meyer, Puneeth Iyengar, Chul Ahn, Kenneth D. Westover, Hak Choy & Robert Timmerman. (2015) Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios as Prognostic Factors after Stereotactic Radiation Therapy for Early-Stage Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology 10:2, pages 280-285.
Crossref
David G. Watt, Campbell S. Roxburgh, Mark White, Juen Zhik Chan, Paul G. Horgan & Donald C. McMillan. (2015) A Survey of Attitudes towards the Clinical Application of Systemic Inflammation Based Prognostic Scores in Cancer. Mediators of Inflammation 2015, pages 1-7.
Crossref
Cirino Botta, Annamaria Gullà, Pierpaolo Correale, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2014) Myeloid-Derived Suppressor Cells in Multiple Myeloma: Pre-Clinical Research and Translational Opportunities. Frontiers in Oncology 4.
Crossref
Pingping Hu, Hongchang Shen, Guanghui Wang, Ping Zhang, Qi Liu & Jiajun Du. (2014) Prognostic Significance of Systemic Inflammation-Based Lymphocyte- Monocyte Ratio in Patients with Lung Cancer: Based on a Large Cohort Study. PLoS ONE 9:10, pages e108062.
Crossref
Gui-Nan Lin, Jie-Wen Peng, Jian-jun Xiao, Dong-Ying Liu & Zhong-Jun Xia. (2014) Prognostic impact of circulating monocytes and lymphocyte-to-monocyte ratio on previously untreated metastatic non-small cell lung cancer patients receiving platinum-based doublet. Medical Oncology 31:7.
Crossref
Ahmet Dirican, Umut Varol, Yuksel Kucukzeybek, Ahmet Alacacioglu, Cigdem Erten, Isil Somali, Alper Can, Lutfiye Demir, Ibrahim Vedat Bayoglu, Murat Akyol, Yasar Yildiz, Betul Koyuncu, Eyup Coban & Mustafa Oktay Tarhan. (2014) Treatment of Metastatic Colorectal Cancer With or Without Bevacizumab: Can the Neutrophil/Lymphocyte Ratio Predict the Efficiency of Bevacizumab?. Asian Pacific Journal of Cancer Prevention 15:12, pages 4781-4786.
Crossref
Caroline Hilmi & Gilles Pagès. 2014. Anti-Angiogenesis Drug Discovery and Development. Anti-Angiogenesis Drug Discovery and Development 112 131 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.